États-Unis · Plateformes & données · The Motley Fool

Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy?

Publié par The Motley Fool · États-Unis il y a 39 min

Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy? — Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy? · The Motley Fool

Résumé détaillé

These healthcare dividend stocks appeal to investors in different ways.

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

À lire aussi

Microsoft services fully restored after outage

Bernicke Wealth Management Ltd. Makes New Investment in Intel Corporation $INTC

Cloudastructure founder Bentley sells $2,370 in shares

FAA lifts rare nationwide ground stop on flights; air travel may take days to recover

Prediction: Nov. 18 Will Be a Massive Day for the Stock Market

Jensen Huang Misled Nvidia Leadership, Lawyer On Affair With Alleged Chinese Spy: Report